The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on percutaneous cementoplasty for palliative treatment of bony malignancies.

Description

Percutaneous cementoplasty is the injection of acrylic bone cement into malignant or benign bone cavities in order to relieve pain and/or stabilise the bone.

Percutaneous cementoplasty may be performed under general anaesthetic or more commonly, using conscious sedation and local anaesthesia affecting the skin, subcutaneous tissue and the periosteum of the bone into which the needle will be introduced. Access to the bone is percutaneous.

Coding and clinical classification codes for this guidance.

Your responsibility

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.

Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.